Arrow Mark Colorado Holdings LLC Spectrum Pharmaceuticals Inc Transaction History

Arrow Mark Colorado Holdings LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $1.97 Million - $3.71 Million	-1,074,964 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.5 - $10.35 $12.5 Million - $37 Million	-3,571,279 Reduced 76.86%	1,074,964 $3.91 Million
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $6.03 Million - $8.32 Million	857,480 Added 22.63%	4,646,243 $38.5 Million
Q2 2019 Aug 14, 2019	BUY	$7.36 - $11.26 $1.89 Million - $2.89 Million	256,972 Added 7.28%	3,788,763 $32.6 Million
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $5 Million - $6.53 Million	551,105 Added 18.49%	3,531,791 $37.8 Million
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $3.81 Million - $10.1 Million	596,959 Added 25.04%	2,980,686 $26.1 Million
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $38.5 Million - $57.9 Million	2,333,403 Added 4636.76%	2,383,727 $40 Million
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $720,136 - $1.09 Million	50,324 New	50,324 $1.06 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.